BioSpace News Archive

American College of Foot and Ankle Surgeons and American Association of Nurse Practitioners® publish interdisciplinary, joint statement

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it has expanded the Alnylam Act® program to include no-charge, third-party genetic testing and counseling for adults and children who may have mutations in alanine-glyoxylate aminotransferase

“We were inspired by a girl who had a cracked and rotted front tooth. She could not afford to have the tooth pulled and desired a product that would snap atop her tooth with a normal appearance,” said inventors from Sun Valley, Calif. “This inspired us to develop a quick fix for a temporary attractive smile.”

Incorporate Massage, the leader in onsite corporate massage and wellness, has announced that Pamela E. Stevenson has joined its Board of Directors.

Health Canada officials to hold a media technical briefing on the Assisted Human Reproduction Act.

NxGen MDx announced the creation of the NxGen MDx Hereditary Cancer Panel, which will test for variants in 32 genes known to cause certain forms of hereditary cancer.

SLI, housed at Magnify, is focused on revolutionizing tissue repair and disrupting the billion dollar scar treatment and chronic wound healing industries.

Innovation unlocks previously inaccessible cellular information and makes more experiments feasible in proteogenomics, immune monitoring, and single-cell genomics

Proof-of-concept study indicates utility of patient-derived cells for evaluating drug response

The FDA grants Priority Review to medicines that have the potential to provide significant improvements in the treatment of a serious disease.